RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies.

about

Nanocarrier based approaches for targeting breast cancer stem cells.Ascorbate-conjugated nanoparticles for promoted oral delivery of therapeutic drugs via sodium-dependent vitamin C transporter 1 (SVCT1).

P2860

Q48209273-99E1D159-7ACB-4028-A76F-F0175EF00E71 Q52743005-39D725E8-E816-4419-B8E9-C9D1BF9BF087

P2860

RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies.

Item

http://www.wikidata.org/entity/Q51053600

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

RAGE receptor targeted bioconj ...... east cancer: in vitro studies.

@en

RAGE receptor targeted bioconj ...... east cancer: in vitro studies.

@nl

type

Item

label

RAGE receptor targeted bioconj ...... east cancer: in vitro studies.

@en

RAGE receptor targeted bioconj ...... east cancer: in vitro studies.

@nl

prefLabel

RAGE receptor targeted bioconj ...... east cancer: in vitro studies.

@en

RAGE receptor targeted bioconj ...... east cancer: in vitro studies.

@nl

P1476

RAGE receptor targeted bioconj ...... east cancer: in vitro studies.

@en

P2093

S Nandha Kumar

http://www.w3.org/2001/XMLSchema#string

Shashank Tummala

http://www.w3.org/2001/XMLSchema#string

Venkata Talluri Siddhartha

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular portraits of human breast tumours

Folate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistance

Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes.

RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment

Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study.

Chemopreventive activity of vitamin E in breast cancer: a focus on γ- and δ-tocopherol

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines.

Molecular subtypes in breast cancer evaluation and management: divide and conquer.

Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.

P304

387-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21691401.2017.1313267

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pavan Kumar Chintamaneni

Sai Kiran S S Pindiprolu

P577

2017-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28415882

http://www.w3.org/2001/XMLSchema#string

RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies.

about

P2860

P2860

RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698